News | February 28, 2024
Bristol Myers Squibb inaugurates new US$100 million facility in Hyderabad
The facility will accommodate over 1,500 employees
The facility will accommodate over 1,500 employees
The U.S. FDA recently approved Xolair as the first and only medicine for children and adults with one or more food allergies
Survodutide has potential to become best-in-class treatment for metabolic dysfunction-associated steatohepatitis
Pfizer INDovation program partners with NIPER Ahmedabad to incubate healthcare startups
VeerHealth Care will be raising Rs. 8 crores through bank borrowings
Orchid is the first company from India, ever to have invented a product which has received a New Drug Approval (NDA) from USFDA
_256_384.jpg)
The Vice President also highlighted the importance of preventive healthcare and fitness
The acquisition of Healint aligns with Aptar Digital Health’s strategy to broaden its portfolio in neurology and strengthen its global footprint for digital health deployment
Net product sales in the fourth quarter of 2023 include the recognition of $0.6 billion from deferred revenue, related to Gavi, the Vaccine Alliance
We are achieving the target of developed India by making our young children healthy today
Subscribe To Our Newsletter & Stay Updated
